Uniqure NV (NASDAQ:QURE)
| 68.88 Delayed Data As of Dec 12 |  +3.45 / +5.27%Today’s Change | 24.07 Today|||52-Week Range 82.49 | +139.00% Year-to-Date |
Latest QURE News | Press Releases
| Here's Why uniQure Is Rallying 13% Today Dec 03 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 65.43 |
| Today’s open | 65.22 |
| Day’s range | 65.07 - 69.08 |
| Volume | 687,980 |
| Average volume (3 months) | 559,749 |
| Market cap | $2.9B |
Data as of 4:00pm ET, 12/12/2019
Growth & Valuation
| Earnings growth (last year) | +20.50% |
| Earnings growth (this year) | -18.95% |
| Earnings growth (next 5 years) | -26.60% |
| Revenue growth (last year) | -13.91% |
| P/E ratio | NM |
| Price/Sales | 91.03 |
| Price/Book | 13.74 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZLABZai Lab Ltd | +1.13 | +2.70% |
| EBSEmergent BioSolution... | +0.71 | +1.33% |
| HALOHalozyme Therapeutic... | -0.02 | -0.11% |
| DCPHDeciphera Pharmaceut... | +0.55 | +0.94% |
Data as of 6:30pm ET, 12/12/2019
Financials
| Next reporting date | March 11, 2020 |
| EPS forecast (this quarter) | -$0.71 |
| Annual revenue (last year) | $11.3M |
| Annual profit (last year) | -$83.3M |
| Net profit margin | -738.25% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Amsterdam, Noord-holland |
Forecasts
